Detalhe da pesquisa
1.
Evaluation of daily patch application duration for epicutaneous immunotherapy for peanut allergy.
Allergy Asthma Proc;
41(4): 278-284, 2020 07 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32517847
2.
An evaluation of factors influencing response to epicutaneous immunotherapy for peanut allergy in the PEPITES trial.
Allergy Asthma Proc;
41(5): 326-335, 2020 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32539908
3.
Best practices for the development, scale-up, and post-approval change control of IR and MR dosage forms in the current quality-by-design paradigm.
AAPS PharmSciTech;
15(3): 665-93, 2014 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24578237
4.
Passive transdermal systems whitepaper incorporating current chemistry, manufacturing and controls (CMC) development principles.
AAPS PharmSciTech;
13(1): 218-30, 2012 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22215291
5.
FDA review summary: Mozobil in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation.
Oncology;
78(3-4): 282-8, 2010.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20530974
6.
Adhesion Evaluation of AG200-15: An Investigational Transdermal Contraceptive Delivery System.
Adv Ther;
36(12): 3381-3389, 2019 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31602573
7.
Folotyn (pralatrexate injection) for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma: U.S. Food and Drug Administration drug approval summary.
Clin Cancer Res;
16(20): 4921-7, 2010 Oct 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20739433